Back to Search
Start Over
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling.
- Source :
- Signal Transduction & Targeted Therapy; 8/9/2024, Vol. 9 Issue 1, p1-13, 13p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 20959907
- Volume :
- 9
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Signal Transduction & Targeted Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 178912463
- Full Text :
- https://doi.org/10.1038/s41392-024-01915-z